Cvs Health (CVS) Non Operating Interest Expenses (2009 - 2026)

Cvs Health (CVS) has reported Non Operating Interest Expenses for 15 consecutive years, with $757.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses fell 0.79% year-over-year to $757.0 million; the trailing twelve-month figure through Jun 2026 stood at $3.1 billion (up 1.44% YoY), and the FY2025 full-year result was $3.1 billion, up 5.44% from the prior year.
• Non Operating Interest Expenses retreated to $757.0 million in Q2 2026 per CVS's latest filing, from $774.0 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $787.0 million in Q4 2025 and bottomed at $552.0 million in Q4 2022.
• Historically, Non Operating Interest Expenses has averaged $697.4 million across 5 years, with a median of $724.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses dropped 10.81% in 2022, then gained 25.0% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $552.0 million in 2022, then increased by 25.0% to $690.0 million in 2023, then gained by 9.86% to $758.0 million in 2024, then increased by 3.83% to $787.0 million in 2025, then decreased by 3.81% to $757.0 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $757.0 million, $774.0 million, and $787.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.